We are live on ! Find out more
ONC

BeOne Medicines Ltd
ONC

200 hedge funds and large institutions have $8.47B invested in BeOne Medicines Ltd in 2023 Q3 according to their latest regulatory filings, with 20 funds opening new positions, 68 increasing their positions, 70 reducing their positions, and 26 closing their positions.

New
Increased
Maintained
Reduced
Closed

58% more call options, than puts

Call options by funds: $16.8M | Put options by funds: $10.6M

1% more capital invested

Capital invested by funds: $8.4B → $8.47B (+$63.8M)

0.02% more ownership

Funds ownership: 3.77% → 3.78% (+0.02%)

0% more funds holding in top 10

Funds holding in top 10: 8 → 8 (0)

3% less repeat investments, than reductions

Existing positions increased: 68 | Existing positions reduced: 70

4% less funds holding

Funds holding: 208 → 200 (-8)

23% less first-time investments, than exits

New positions opened: 20 | Existing positions closed: 26

Holders
200
Holders Change
-8
Holders Change %
-3.85%
% of All Funds
3.17%
Holding in Top 10
8
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.13%
New
20
Increased
68
Reduced
70
Closed
26
Calls
$16.8M
Puts
$10.6M
Net Calls
+$6.15M
Net Calls Change
+$25.3M

Top Buyers

1
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$116M
2
Canada Life
Canada Life
Manitoba, Canada
+$54M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
+$52.4M
4
Fidelity Investments
Fidelity Investments
Massachusetts
+$13.7M
5
TD Asset Management
TD Asset Management
Ontario, Canada
+$9.5M

Top Sellers

1
Capital International Investors
Capital International Investors
California
-$48.3M
2
PBA
Paradigm Biocapital Advisors
New York
-$38.5M
3
Bank of America
Bank of America
North Carolina
-$21.9M
4
Invesco
Invesco
Georgia
-$14.1M
5
CII
Capital International Inc
California
-$13.9M
Name Holding Trade Value Shares
Change 		Change in
Stake
BNP Paribas Asset Management
26
BNP Paribas Asset Management
France
$17.2M +$362K +1,832 +2%
AI
27
Axiom Investors
Connecticut
$15.8M -$8.21M -41,490 -32%
TCM
28
Tang Capital Management
California
$15.3M – – –
EDRH
29
Edmond de Rothschild Holding
Switzerland
$14.7M +$5.07M +25,610 +45%
Goldman Sachs
30
Goldman Sachs
New York
$14M +$1.37M +6,935 +10%
ZAM
31
Zeal Asset Management
Hong Kong
$13.1M – – –
HSBC Holdings
32
HSBC Holdings
United Kingdom
$11.8M +$4.7M +23,744 +57%
SEI Investments
33
SEI Investments
Pennsylvania
$11.5M -$1.56M -7,892 -11%
CI
34
Capital International
California
$11.4M -$78.6K -397 -0.6%
N
35
Nuveen
North Carolina
$11.4M +$1.98M +10,000 +19%
MICM
36
Matthews International Capital Management
California
$11M -$13.2M -66,847 -52%
Royal Bank of Canada
37
Royal Bank of Canada
Ontario, Canada
$10.8M -$594K -3,001 -5%
Axa
38
Axa
France
$10.1M -$38.2K -193 -0.3%
Wellington Management Group
39
Wellington Management Group
Massachusetts
$9.98M +$4M +20,239 +57%
TAMH
40
Taikang Asset Management (HK)
Hong Kong
$9.86M – – –
Norges Bank
41
Norges Bank
Norway
$9.71M – – –
BG
42
Bellevue Group
Switzerland
$9.5M +$8.51M +43,000 +422%
Wells Fargo
43
Wells Fargo
California
$9.17M -$1.69M -8,525 -14%
Millennium Management
44
Millennium Management
New York
$8.47M -$12.6M -63,864 -58%
Envestnet Asset Management
45
Envestnet Asset Management
Illinois
$8.4M +$3.22M +16,295 +54%
Canada Life
46
Canada Life
Manitoba, Canada
$8.33M +$54M +273,087 +529%
JFG
47
Jefferies Financial Group
New York
$8.27M +$9.1M +46,000 New
Jane Street
48
Jane Street
New York
$7.05M +$6.76M +34,143 +674%
Geode Capital Management
49
Geode Capital Management
Massachusetts
$6.44M +$40K +202 +0.6%
Manulife (Manufacturers Life Insurance)
50
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$6.2M +$184K +932 +3%
1
2
3 4 5

ONC Hedge Fund Activity: Q3 2023 in Review

200 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q3 2023, worth a combined $8.47B — up 0.76% from $8.4B a quarter earlier.

Sellers outnumbered buyers: 26 funds closed out of ONC and 20 opened new positions — a net loss of 6 holders — while 70 trimmed existing stakes and 68 added.

The largest buyer was Baillie Gifford & Co, adding an estimated $116M. The largest seller was Capital International Investors, cutting an estimated $48.3M.

  • 200 institutional investors held BeOne Medicines Ltd (ONC) as of Q3 2023, down from 208 in Q2 2023.
  • Funds reported $8.47B of BeOne Medicines Ltd stock for Q3 2023, up 0.76% quarter-over-quarter.
  • 20 funds opened new BeOne Medicines Ltd positions in Q3 2023 and 26 closed out, a net change of -6 holders.
  • The largest BeOne Medicines Ltd buyer in Q3 2023 was Baillie Gifford & Co, an estimated $116M added.
  • The largest BeOne Medicines Ltd seller in Q3 2023 was Capital International Investors, an estimated $48.3M sold.

Based on aggregated 13F filings for Q3 2023.